Method of administration and treatment
AssigneeDyve Biosciences, Inc.
InventorRyan BEAL
Life of this patent
Estimating the term…
Abstract
Provided herein are formulations for topical and/or transdermal administration, and methods of using these formulations for the treatment of proliferative diseases related to cancer such as cancers and related conditions, and solid tumors. Also provided are formulations for topical and/or transdermal administration, and methods of using these formulations for melasma, gout, skin disorders, and other diseases and disorders described herein as well as methods for modulating the pH (e.g. raising) of a tissue or microenvironment proximal to a tumor, modulating pH, or improving the effectiveness of know chemotherapeutic agents, immunotherapy and the like for the prevention, treatment of cancers and related conditions described herein.
Claims20
A formulation suitable for transdermal delivery of a buffering agent, the formulation comprising the buffering agent and tranexamic acid;
- wherein the buffering agent comprises sodium carbonate, sodium bicarbonate, and/or triethanolamine.
A formulation suitable for transdermal delivery, the formulation comprising about 1% w/w sodium carbonate and/or about 1% w/w sodium bicarbonate and about 6% tranexamic acid,
- wherein the formulation further comprises benzyl alcohol, isopropyl palmitate (IPP), water, a poloxamer, and Durosoft®, and a lecithin,
- wherein the lecithin is selected from an egg lecithin, a soy lecithin, and a synthetic lecithin;
- and
- wherein the formulation is formulated as a cream, lotion, or ointment.
Dependencies are inferred from the claim text.